Publications by authors named "Maxi Wass"

Claim this Profile
R
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Maxi Wass

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Julius C Enßle, Sebastian Wolf, Sebastian Scheich, Sarah Weber, Michael Kramer, Maxi Wass

Br J Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, Johannes Krisam, Martin Görner, Maxi Wass

Trials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation.
Judith Schaffrath, Tanja Diederichs, Susanne Unverzagt, Maxi Wass, Ulrike Gläser

Ann Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19.
Christoph Schultheiß, Lisa Paschold, Edith Willscher, Donjete Simnica, Anna Wöstemeier, Maxi Wass

iScience· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Maxi Wass

Blood Cancer J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation.
Benjamin Thiele, Mascha Binder, Simon Schliffke, Christian Frenzel, Judith Dierlamm, Maxi Wass

Oncol Res Treat· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy.
Maxi Wass, Stefanie Göllner, Birgit Besenbeck, Richard F Schlenk, Petra Mundmann

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Christoph Röllig, Michael Kramer, Christoph Schliemann, Jan-Henrik Mikesch, Björn Steffen, Maxi Wass

Blood· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Maxi Wass, Marcus Bauer, Roald Pfannes, Kerstin Lorenz, Andreas Odparlik

BMC Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia.
Maxi Wass, Friederike Hitz, Judith Schaffrath, Carsten Müller-Tidow, Lutz P Müller

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response.
Maxi Wass, Timo Behlendorf, Bärbel Schädlich, Anja Mottok, Andreas Rosenwald

Eur J Haematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis